Pseudophakic cystoid macular edema.

Area of Science:

• Ophthalmology
• Retinal diseases
• Surgical complications

Background:

• Cystoid macular edema (CME) is a significant cause of reduced vision following cataract surgery, with an incidence of 1-2% in modern techniques.
• Diagnosis involves clinical examination and fluorescein angiography, revealing perifoveal leakage due to inflammatory mediators causing intraretinal fluid accumulation.

Purpose of the Study:

• To review the incidence, diagnosis, risk factors, and controversial treatment strategies for cystoid macular edema post-cataract surgery.
• To evaluate the evidence for non-steroidal anti-inflammatory drug (NSAID) prophylaxis in preventing clinical CME.

Main Methods:

• Review of existing literature on cystoid macular edema following cataract surgery.
• Analysis of diagnostic methods including clinical examination and fluorescein angiography.
• Discussion of various treatment modalities and the role of NSAID prophylaxis.

Main Results:

• CME is a known complication of cataract surgery, linked to factors like posterior capsule rupture and diabetes.
• Treatment approaches range from observation to NSAIDs, steroids, and surgery, with no universally agreed-upon standard.
• Current evidence provides limited support for the long-term visual outcome benefits of peri-operative NSAID prophylaxis.

Conclusions:

• Cystoid macular edema remains a challenge in cataract surgery, necessitating careful management.
• The efficacy of NSAID prophylaxis for long-term visual outcomes in preventing CME requires further investigation.
• Management strategies for post-cataract surgery CME are varied and often controversial.